Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
9.86M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
255K
-
Shares change
-
+145K
-
Total reported value, excl. options
-
$790K
-
Value change
-
+$462K
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$2.98
Significant Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q3 2024
11 filings reported holding NRXS - Neuraxis, INC - Common Stock, par value $0.001 per share as of Q3 2024.
Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 255K shares
of 9.86M outstanding shares and own 2.59% of the company stock.
Largest 10 shareholders include BANK OF MONTREAL /CAN/ (149K shares), VANGUARD GROUP INC (28K shares), STIFEL FINANCIAL CORP (25.7K shares), GEODE CAPITAL MANAGEMENT, LLC (22.7K shares), Royal Bank of Canada (15.1K shares), PARSONS CAPITAL MANAGEMENT INC/RI (13K shares), Tower Research Capital LLC (TRC) (1.9K shares), BANK OF AMERICA CORP /DE/ (26 shares), JPMORGAN CHASE & CO (8 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.